Sort
82,697 grants matching “vaccine development”
SUPPORT SERVICES FOR HIV AIDS CLINICAL TRIAL NETWORKS
$1,972,938Barbara Driver · Westat, Inc. · N01 · FY2024 · HD
Vanderbilt Vaccine and Treatment Evaluation Unit
$1,972,714Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2023 · AI
Mechanisms and Immunological Consequences of Host-Virus Interactions
$1,972,162Ulrich H Von Andrian · Harvard Medical School · P01 · FY2014 · AI
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus
$1,972,132Hildegund C. J. Ertl · Wistar Institute · P01 · FY2006 · AI
Medicinal Chemistry Optimization of Anti-Alphaviral Leads and Elucidation of Target and Off Target Engagement
$1,971,109Jennifer E. Golden · University Of Tennessee Health Sci Ctr · U19 · FY2023 · AI
Retrovirus Models of Cancer
$1,971,061Lee Ratner · Washington University · P01 · FY2025 · CA
Integrated Support Services
$1,970,888Joan Elizabeth Nichols · University Of Texas Med Br Galveston · UC7 · FY2011 · AI
UCLA AIDS Prevention and Treatment Clinical Trials Unit
$1,970,379Judith S. Currier · University Of California Los Angeles · U01 · FY2009 · AI
Immune correlates of protection
$1,970,186Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Molecular Determinants of Tissue-resident Memory T cell Fate in Acute and Chronic Infection
$1,969,969Ananda W Goldrath · University Of California, San Diego · P01 · FY2020 · AI
Preclinical Development of Flagellin as a Mucosal Adjuvant in Biodefense Vaccines
$1,969,516Steven B. Mizel · Wake Forest University Health Sciences · U01 · FY2007 · AI
Host-pathogen competition in IFN mediated antiviral defense
$1,969,262Jae U Jung · University Of Southern California · U19 · FY2009 · AI
The Molecular Pathogenesis of Varicella Zoster Virus Infection
$1,968,529Donald Gilden · University Of Colorado Denver · P01 · FY2014 · AG
Colorado Head and Neck Cancer SPORE
$1,968,453Antonio Jimeno · University Of Colorado Denver · P50 · FY2021 · CA
WaNPRC Macaca nemestrina SPF Breeding Colony
$1,967,610Donald Rick Lee · University Of Washington · U42 · FY2012 · OD
Combination immunotherapy with gene modified CD4 and CD8 T cells and stem cells
$1,967,243Carl H. June · University Of Pennsylvania · U19 · FY2009 · AI
VACCINATION AGAINST INTRAPARTUM HIV CLADE C TRANSMISSION
$1,966,903Dana-Farber Cancer Institute · P01 · FY2003 · AI
improving outcomes after stem cell transplantation
$1,966,744Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
Tuberculosis Imaging Program
$1,966,416Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIC · FY2019 · AI
Immunopathogenesis of Acute HIV-1 Infection
$1,966,328University Of Colorado Denver · P01 · FY2004 · AI
United States Military HIV Research Program (MHRP) Clinical Trials Unit
$1,966,176Julie A. Ake · Walter Reed Army Institute Of Research · UM1 · FY2020 · AI
Reagent Resource Support Program for AIDS Vaccine Development
$1,965,925Valerie Fremont · Quality Biological, Inc. · N01 · FY2021 · AI
Radiation Survivor Core
$1,965,905J. Mark Cline · Duke University · U19 · FY2019 · AI
Pathogenesis and countermeasures of poxviruses and hemorrhagic fever viruses
$1,965,696Peter Jahrling · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
DEVELOPMENT OF VACCINES FOR INFLUENZA USING AN IMMUNO-MODULATOR ADJUVANT AND MULTI-PLATFORM APPROACH
$1,964,933Bruxanne El-Kammash · University Of Chicago · N01 · FY2023 · AI